Manish Mital
@Braidwell Lp
Latest period2024 - Q3ReportedManaged Assets$3.528BTotal holdings81
Assets growth rate10.68%Assets growth rate (2-Q avg)6.71%Continuous growth in asset value3 quarters
Portfolio positions
This chart displays the top 10 holdings in Braidwell Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.
Assets under management
The assets under management (AUM) of Braidwell Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.528B in assets, with a quarterly growth rate of 10.68% and a 2-quarter average growth rate of 6.71%. The portfolio is managed by Manish Mital, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
4633⤦Ironwood Pharmaceuticals Inc
| 2.34% | $82.465M 92.74M shares@ $0.89 avg price | Increased 3.35% |
2521⤦Dexcom Inc
| 2.34% | $82.271M 92.7M shares@ $0.89 avg price | Increased 12.1% |
ALGNAlign Technology Inc
| 2.25% | $79.266M 311,679 shares@ $254.32 avg price | Increased 13.26% |
GHGuardant Health Inc
| 2.18% | $76.668M 3.342M shares@ $22.95 avg price | Increased 19.03% |
4578⤦Insulet Corp
| 2.17% | $76.385M 63.8M shares@ $1.2 avg price | Decreased -6.17% |
LEGNLegend Biotech Corp
| 2.13% | $75.12M 1.542M shares@ $48.73 avg price | Decreased -7.67% |
VKTXViking Therapeutics Inc
| 2.08% | $73.248M 1.157M shares@ $63.32 avg price | Increased 4.53% |
KNSAKiniksa Pharmaceuticals Intl
| 2.06% | $72.334M 2.895M shares@ $25.0 avg price | Increased 40.63% |
PENPenumbra Inc
| 2% | $70.229M 361,428 shares@ $194.32 avg price | Increased 70.01% |
2521⤦Dexcom Inc
| 1.99% | $70.137M 73.5M shares@ $0.96 avg price |